Evidence map›Paper›PMID 26075269›Full record

ReviewBioMed research international2015

New and emerging strategies in platelet-rich plasma application in musculoskeletal regenerative procedures: general overview on still open questions and outlook.

Francesca Salamanna, Francesca Veronesi, Melania Maglio, Elena Della Bella, Maria Sartori, Milena Fini

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03371888 (The Platelet -Rich Plasma in the Therapy of Temporomandibular Disorders), which is not on this map. Cited by 30 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 3 pooled it
9.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03371888 phase2 / phase3completednot on this mapstarted 2017, after this paper: background citation

The Platelet -Rich Plasma in the Therapy of Temporomandibular Disorders

TypeinterventionalSponsorMedical University of SilesiaRan2017 to 2019Enrolled58ConditionsPRP, Temporomandibular Disorder, Myalgia, BruxismArmsPlatelet-Rich Plasma intramuscular injections, Placebo Comparator: 0,9% NaCl intramuscular injections
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 3 syntheses or guidelines pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Francesca SalamannaLaboratory of Biocompatibility, Innovative Technologies and Advanced Therapies, Department Rizzoli RIT, Rizzoli Orthopedic Institute, Via di Barbiano 1/10, 40136 Bologna, Italy.ORCID 0000-0001-7402-4054
Francesca VeronesiLaboratory of Biocompatibility, Innovative Technologies and Advanced Therapies, Department Rizzoli RIT, Rizzoli Orthopedic Institute, Via di Barbiano 1/10, 40136 Bologna, Italy.
Melania MaglioLaboratory of Preclinical and Surgical Studies, Rizzoli Orthopedic Institute, Via di Barbiano 1/10, 40136 Bologna, Italy.
Elena Della BellaLaboratory of Preclinical and Surgical Studies, Rizzoli Orthopedic Institute, Via di Barbiano 1/10, 40136 Bologna, Italy ; Department of Specialized, Experimental, and Diagnostic Medicine, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.ORCID 0000-0001-5151-7390
Maria SartoriLaboratory of Biocompatibility, Innovative Technologies and Advanced Therapies, Department Rizzoli RIT, Rizzoli Orthopedic Institute, Via di Barbiano 1/10, 40136 Bologna, Italy.
Milena FiniLaboratory of Biocompatibility, Innovative Technologies and Advanced Therapies, Department Rizzoli RIT, Rizzoli Orthopedic Institute, Via di Barbiano 1/10, 40136 Bologna, Italy ; Laboratory of Preclinical and Surgical Studies, Rizzoli Orthopedic Institute, Via di Barbiano 1/10, 40136 Bologna, Italy.
Istituto Ortopedico Rizzoli · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite its pervasive use, the clinical efficacy of platelet-rich plasma (PRP) therapy and the different mechanisms of action have yet to be established. This overview of the literature is focused on the role of PRP in bone, tendon, cartilage, and ligament tissue regeneration considering basic science literature deriving from in vitro and in vivo studies. Although this work provides evidence that numerous preclinical studies published within the last 10 years showed promising results concerning the application of PRP, many key questions remain unanswered and controversial results have arisen. Additional preclinical studies are needed to define the dosing, timing, and frequency of PRP injections, different techniques for delivery and location of delivery, optimal physiologic conditions for injections, and the concomitant use of recombinant proteins, cytokines, additional growth factors, biological scaffolds, and stems cells to develop optimal treatment protocols that can effectively treat various musculoskeletal conditions.

Indexed as

Platelet-Rich PlasmaAnimalsBone RegenerationCartilageHumansLigamentsTendon InjuriesTendons

Identifiers

PMID26075269
PMCPMC4436449
OpenAlexW1499341899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.